TABLE 2.

Unadjusted and adjusted analyses of neutrophil count (×10⁹/L), leukocyte count (×10⁹/L), NLR with mRS 0–2 at 90days.

Parameters	Cell counts (109/L) in quartiles	Unadjusted analysis		Model 1†		Model 2‡
		OR (95% CI)	p value	OR (95% CI)	p value	OR (95% CI)	p value
Leukocyte	<8.40	Reference	<0.001	Reference	0.007	Reference	0.008
	8.40–11.06	0.55(0.34–0.89)	0.015	0.51(0.26–0.97)	0.041	0.52(0.26–1.04)	0.064
	11.06–13.66	0.34(0.20–0.57)	<0.001	0.42(0.21–0.82)	0.011	0.38(0.19–0.77)	0.007
	>13.66	0.33(0.19–0.55)	<0.001	0.32(0.16–0.64)	0.001	0.31(0.15–0.64)	0.002
Neutrophil	<6.60	Reference	<0.001	Reference	0.001	Reference	0.002
	6.60–9.15	0.47(0.29–0.77)	0.002	0.43(0.22–0.83)	0.011	0.50(0.25–0.99)	0.047
	9.15–11.96	0.38(0.23–0.63)	<0.001	0.53(0.27–1.01)	0.055	0.48(0.24–0.96)	0.038
	>11.96	0.27(0.16–0.46)	<0.001	0.23(0.11–0.47)	<0.001	0.22(0.11–0.48)	<0.001
NLR	<4.96	Reference	<0.001	Reference	0.001	Reference	0.001
	4.96–7.93	0.58(0.36–0.95)	0.030	0.46(0.24–0.87)	0.018	0.46(0.23—-0.91)	0.027
	7.93–12.63	0.45(0.27–0.74)	0.002	0.45(0.23–0.89)	0.021	0.41(0.20–0.84)	0.016
	>12.63	0.32(0.19–0.55)	<0.001	0.22(0.11–0.44)	<0.001	0.21(0.10–0.46)	<0.001
Leukocyte, 109/L		0.89(0.84–0.93)	<0.001	0.88(0.83–0.94)	<0.001	0.88(0.82–0.95)	<0.001
Neutrophil, 109/L		0.88(0.83–0.93)	<0.001	0.87(0.81–0.93)	<0.001	0.87(0.81–0.93)	<0.001
NLR		0.95(0.92–0.98)	0.001	0.94(0.91–0.98)	0.001	0.94(0.91–0.98)	0.001

^†Model 1 adjusted for age, sex, hypertension, diabetes mellitus, baseline NIHSS score, baseline pc-ASPECTS, PC-CS score, stroke etiology, occlusion sites and pass.

^‡Model 2 excluded patients without successful recanalization and adjusted for confounding factors in model 1.

OR, odds ratio; NLR, neutrophil-to-lymphocyte ratio; mRS, modified Rankin Scale.